Form 483

Allure Labs, LLC Form 483, 2026-03-27

FDA issued a Form 483 to Allure Labs, LLC on 2026-03-27 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Allure Labs, LLC · Hayward, United States · Issued March 27, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Mar 2026
21 CFR 211.165(e)

Test methods

Cited by Nathan E Hellman

27 Mar 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Nathan E Hellman

27 Mar 2026
21 CFR 211.68(b)

Computer control of master formula records

Cited by Nathan E Hellman

Inspected site

ALAllure Labs, LLCHayward, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere